טיקגרלור אינובמד 90 מ"ג - Ticagrelor inovamed 90 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× |
|
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | B01AC Platelet aggregation inhibitors excluding heparin |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Ticagrelor Inovamed , co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event. Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××§×ר××ר ××× ×××× 90 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ZAKLADY FARMACEUTYCZNEâPOLPHARMAâS.A. (PHARMACEUTICAL WORKS âPOLPHARMAâ S.A), POLAND |
| ×©× ××¢× ×ר×ש×× | INOVAMED PHARMA LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 1/2021. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 15/07/2024 |
השינוי האחרון נעשה בֹ־15 ביולי 2024 ב־06:05